EUFEPS conference on Drug Transporters at Copenhagen: Integrative approaches in ADME research

European Journal of Pharmaceutical Sciences

Volumn 26, Issue 1, 2005, Pages 130-143

  Meijer, Dirk K F ^a   Lennernäs, Hans ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; AZASETRON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; BROMSULFOPHTHALEIN; CARDIAC GLYCOSIDE; CARRIER PROTEIN; CERIVASTATIN; CYCLOSPORIN; DIGOXIN; DOXORUBICIN; DRUG METABOLIZING ENZYME; ELACRIDAR; ERYTHROMYCIN; ESTRADIOL; FEXOFENADINE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETOCONAZOLE; PRAVASTATIN; PROBENECID; QUINIDINE; RIFAMPICIN; RIFAMYCIN; ROSUVASTATIN; TALINOLOL; TEMOCAPRILAT; TRAMAZOLINE; UNINDEXED DRUG; VERAPAMIL;

BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL INTERACTION; CELL LINE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DOSE RESPONSE; DRUG BILE LEVEL; DRUG BINDING; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SCREENING; DRUG TRANSPORT; HUMAN; HYPERBILIRUBINEMIA; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; KIDNEY CELL; LIVER METABOLISM; LIVER MICROSOME METABOLISM; MEDICAL RESEARCH; MEMBRANE TRANSPORT; METHODOLOGY; MOLECULAR INTERACTION; NONHUMAN; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

EID: 23244435554     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2005.07.001     Document Type: Conference Paper

References (36)

1. P.P. Annaert R.Z. Turncliff C.L. Booth D.R. Thakker Brouwer KLR P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes Drug Metab. Dispos. 29 2001 1277 1283
2. L.Z. Benet C.L. Cummins C.-Y. Wu Transporter-enzyme interactions: implications for predicting drug–drug interactions from in vitro data Curr. Drug Metab. 4 2003 393 398
3. P. Borst R. Oude Elferink Mammalian ABC transporters in health and disease Annu. Rev. Biochem. 71 2002 537 592
4. G. Burckhardt N.A. Wolff Structure of renal organic anion and cation transporters Am. J. Physiol. Renal. Physiol. 278 2000 F853 F866
5. P. Chandra K.L.R. Brouwer The complexities of hepatic drug transport: current knowledge and emerging concepts Pharm. Res. 21 2004 719 735
6. P. Dazert K. Meissner S. Vogelgesang B. Eydrich L. Eckel M. Bohm R. Warzok B. Kerb U. Brinkmann E. Schaeffeler M. Schwab I. Cascorbi G. Jedlitschky H.K. Kroemer Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart Am. J. Pathol. 164 2003 1567 1577
7. A.G. De Boer I.C. van der Sandt P.J. Gaillard The role of drug transporters at the blood–brain barrier Ann. Rev. Pharmacol. Toxicol. 43 2003 629 656
8. R. De Kanter M. Monshouwer D.K.F. Meijer G.M.M. Groothuis Precision cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues Curr. Drug Metab. 3 2002 39 59
9. K.N. Faber M. Müller P.L.M. Jansen Drug transport proteins in the liver Adv. Drug Deliv. Rev. 55 2003 107 124
10. B. Hagenbuch P.J. Meier Organic anion transporting polypeptides of the OATP/SLC21 family: phyogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties Pflügers Arch. 447 2004 653 665
11. B. Hagenbuch P.J. Meier The superfamily of organic anion transporting polypeptides Biochim. Biophys. Acta 1609 2003 1 18
12. B. Hagenbuch P.J. Meier Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch. 447 2004 663 665
13. B. Hagenbuch P.J. Meier The superfamily of organic anion transporting polypeptides Biochim. Biophys. Acta 10 2003 1 18
14. A. Haimeur G. Conseil R.G. Deeley S.P.C. Cole The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Curr. Drug Metab. 5 2004 21 53
15. G.J.E.J. Hooiveld J.E. van Montfoort D.K.F. Meijer M. Müller Function and regulation of ATP-binding cassette transport proteins involved in hepato-biliary transport Eur. J. Pharm. Sci. 12 2001 525 543
16. H. Koepsell B.M. Schmitt V. Gorboulev Organic cation transporters Rev. Physiol. Biochem. Pharmacol. 150 2003 36 90
17. H. Koepsell Polyspecific organic cation transporters: their functions and interactions with drugs Trends Pharmacol. Sci. 25 2004 375 381
18. H. Koepsell H. Endou The SLC22 drug transporter family Pflugers Arch. 447 2004 666 676
19. Kullak-Ublick, G.A., Stieger, B., Meier, P.J., 2000. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterol. 126:?
20. X. Liu E.L. LeCluyse K.R. Brouwer L.L. Gan J.J. Lemasters B. Stieger P.J. Meier K.L.R. Brouwer Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration Am. J. Physiol. (Gastrointest. Liver Physiol. 40) 277 1999 G12 G21
21. K.M. Mahar Doan J.E. Humphreys L.O. Webster S.A. Wring L.J. Shampine C.J. Serabjit-Singh K.K. Adkison J.W. Polli Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs J. Pharmacol. Exp. Therap. 303 3 2002 1029 1037
22. P.J. Meier B. Stieger Bile salt transporters Annu. Rev. Physiol. 64 2002 635 661
23. Meijer, D.K.F., Jansen, P.L.M., Groothuis, G.M.M., Hepatobiliary disposition and targeting of drugs and genes. In: Oxford Textbook of Clinical Hepatology, vol. 1 (Section 2.4), second ed., 1990, pp. 87–144.
24. D.K.F. Meijer J.W. Smit G.J.E.J. Hooiveld J.E. Van Montfoort P.L.M. Jansen M. Müller The molecular basis for hepatobiliary transport of organic cations and organic anions G.L. Amidon W. Sadee Membrane Transporters as Drug Targets vol. 12 1999 Kluwer Acad./Plenum Publ. New York 89 157
25. N. Mizuno T. Niwa Y. Yotsumoto Y. Sugiyama Impact of drug transporter studies on drug discovery and development Pharmacol. Revs. 55 2003 425 461
26. Y. Nishizato I. Ieiri H. Suzuki M. Kimura Kawabata Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics Clin. Pharmacol. Ther. 73 2003 554 565
27. P. Olinga M.J.H. Slooff D.K.F. Meijer G.M.M. Groothuis Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue Toxicol. In Vitro 12 1998 77 100
28. A.D. Rodrigues Preclinical drug metabolism in the age of high-throuput screening and industrial1perspective Pharm. Res. 14 1997 1504 1510
29. N. Strazielle M.F. Belin J.F. Ghersi-Egea Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters AIDS 17 2003 147
30. T. Sakaeda T. Nakamura K. Okumura Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs Pharmacogenomics 4 2003 397 410
31. H. Sun H. Dai N. Shaik W.F. Elmquist Drug efflux transporters in the CNS Adv. Drug Del. Rev. 55 1 2003 83 105
32. D. Sun H. Lennernas L.S. Welage J.L. Barnett C.P. Landowski D. Foster D. Fleisher K.-D. Lee G.L. Amidon Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm. Res. 19 2002 1400
33. A. Tsuji Transporter-mediated drug interactions Drug Metabol. Pharmacokin. 17 2002 25 274
34. J.E. Van Montfoort B. Hagenbuch G.M. Groothuis H. Koeppsel P.J. Meier D.K.F. Meijer Drug uptake systems in liver and kidney Curr. Drug Metab. 4 2003 185–21
35. R.E. White High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery Ann. Rev. Pharmacol. Toxicol. 40 2000 133 157
36. C.-Y. Wu L.Z. Benet Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system Pharm. Res. 22 2005 11 23